OKYO Pharma Limited (NASDAQ:OKYO) Short Interest Update

OKYO Pharma Limited (NASDAQ:OKYO) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 338,000 shares, a growth of 30.4% from the February 13th total of 259,200 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average daily trading volume, of 150,800 shares, the short-interest ratio is presently 2.2 days.

OKYO Pharma Stock Performance

Shares of OKYO Pharma stock traded down $0.01 during midday trading on Monday, hitting $1.50. The company had a trading volume of 19,914 shares, compared to its average volume of 213,192. The company has a fifty day simple moving average of $1.16 and a 200 day simple moving average of $1.10. OKYO Pharma has a 12-month low of $0.81 and a 12-month high of $1.90.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price objective on shares of OKYO Pharma in a research report on Tuesday, February 18th.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.